|
02/06 2026 Cell therapy, hailed as the “Third Medical Revolution” after small-molecule drugs and antibody drugs, is moving from the laboratory to the clinic and from “sky-high life-saving drugs” to inclusive hea 02/06 2026 Recently, the induced pluripotent stem cells (iPSC) (Vcanbio Induced Pluripotent Stem Cells) independently developed and declared by Union Stem Cell & Gene Engineering Co., Ltd., a subsidiary of Zhong 02/06 2026
The leading enterprise in NK immune cells - Yingbairui invites you to the 15th Cell Biology Industry
Recently, Yingbairui (Hangzhou) Biopharmaceutical Co., Ltd. (hereinafter referred to as "Yingbairui"), an enterprise focusing on the field of NK immune cells, successfully completed a nearly 200 milli 02/06 2026 From March 5th to 6th, Gather Energy Biotechnology (Shanghai) Co., Ltd. will make a grand appearance at the 15th Zhenghe Cell Biology Industry Conference and the 6th International Conference on Cell T 02/06 2026
The 2026 Chengdu Cell Event Kicks Off: Miyen cordially invites everyone to jointly explore the foref
Spring arrives in the beautiful city of Chengdu, and wisdom gathers in Tianfu. In this season of all - things renewing, an annual event that combines scientific research wisdom and industrial strength 02/09 2026
Huixin Biotech leads the exosome track with cutting - edge technology and recently received nearly 1
Recently, Shenzhen Huixin Biomedical Technology Co., Ltd. (hereinafter referred to as "Huixin Biotech") announced the completion of nearly 100 million yuan in Series A+ financing, which was led by Leg |